Co-targeting SOS1 enhances the antitumor effects of KRASG12C inhibitors by addressing intrinsic and acquired resistanceVenu Thatikonda, Marco H. Hofmann|Nature Cancer|2024Cited by 45
Combined KRAS <sup>G12C</sup> and SOS1 inhibition enhances and extends the anti-tumor response in KRAS <sup>G12C</sup> -driven cancers by addressing intrinsic and acquired resistanceVenu Thatikonda, Marco H. Hofmann|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 17